Page
%P
-
Article
194 Superiority of A Novel Surfactant, Surfaxin (Lucinactant), Over Exosurf (Colfosceril Palmitate) in Prevnting Respiratory Distress Syndrome in Very Preterm Infants: A Pivotal, Multinational, Randomized Trial
Background: Animal-derived, protein-containing surfactants perform better vs. non–protein-containing surfactants for the prevention and treatment of Respiratory Distress Syndrome (RDS). A new generation, non–anim...
-
Article
195 Comparison of Incidences of All-Cause Mortality Between The Novel Surfactant, Surfaxin (Lucinactant) and The Animal Derived Surfactants Survanta (Beractant) and Curosurf (Poractant Alfa)
Background: Animal-derived, protein-containing surfactants perform better vs. non–protein-containing surfactants for prevention and treatment of Respiratory Distress Syndrome (RDS). A new generation, non–animal-d...
